CTOs on the Move

Xenter

www.xentermd.com

 
Xenter, Inc. is a privately held company headquartered in Salt Lake City, Utah, that is focused on developing new wireless medical device technologies, innovative digital health tools that will enable individual patients to own and manage their health information, and novel therapeutic drugs utilizing Physical Intelligence™ and patient-supplied data. Xenter has assembled a team of medical scientists, chemical engineers, medical device engineers, researchers, data scientists, and some of the world`s most accomplished entrepreneurs and industry veterans to solve some of the largest challenges in healthcare, medicine and engineering.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.xentermd.com
  • 2463 South 3850 West
    Salt Lake City, UT USA 84120
  • Phone: 385.799.6400

Executives

Name Title Contact Details
Gary Baldwin
 Chief Technology Officer Profile

Funding

Xenter raised $12M on 05/07/2021

Similar Companies

Technical Safety Services

Technical Safety Services is a Berkeley, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

DuVal and Associates PA

DuVal and Associates PA is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cygnus Inc

Cygnus Inc is a Petoskey, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Eugene

Eugene is a Eugene, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pulse Biosciences

Pulse Biosciences is a novel medical therapy company bringing to market its proprietary CellFX™ Nano-Pulse Stimulation™ (NPS™) platform. The Company`s CellFX NPS platform provides a novel, precise, non-thermal, treatment technology delivering nanosecond duration energy pulses that impact cells in treated tissue while sparing acellular tissue. NPS`s unique mechanism of action disrupts the functions of internal cell structures while maintaining the outer cell membrane initiating a cascade of events within the cell that results in regulated cell death.